BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8326704)

  • 21. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early diagnosis and treatment of chorioretinitis in children with congenital toxoplasmosis].
    Gerkowicz K
    Klin Oczna; 1979; 81(2):135-7. PubMed ID: 439718
    [No Abstract]   [Full Text] [Related]  

  • 23. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
    Lebech AM; Lebech M; Børme KK; Mathiesen LR
    Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular toxoplasmosis.
    Hogan MJ
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1969; 50():1-21. PubMed ID: 4924569
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical picture of congenital toxoplasmosis in children hospitalized at the Neonatal Department of the Institute of Pediatrics, Medical Academy, in Lublin].
    Furmaga-Jabłońska W
    Pediatr Pol; 1987 Jun; 62(6):398-403. PubMed ID: 3670931
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of ocular toxoplasmosis. Part 2: Therapeutic approaches].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 Jun; 61(4-5):154-60. PubMed ID: 8361145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
    Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of the results of serological tests carried out during pregnancy for the prevention and diagnosis of congenital toxoplasmosis].
    Lässker G; Degen R; Keller J
    Z Kinderheilkd; 1969; 105(2):132-41. PubMed ID: 5813227
    [No Abstract]   [Full Text] [Related]  

  • 29. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
    J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New trends in ocular toxoplasmosis--the review].
    Borkowski PK
    Przegl Epidemiol; 2001; 55(4):483-93. PubMed ID: 11921736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical criteria of the diagnosis and management of various forms of toxoplasmosis].
    Kociecka W
    Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):809-12. PubMed ID: 2485898
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
    Holland GN
    Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ocular toxoplasmosis. Apropos of 29 cases illustrating the various clinical and serological forms].
    Fontaine M; Desmonts G; Rousselie F
    Arch Ophtalmol Rev Gen Ophtalmol; 1965; 25(7):585-619. PubMed ID: 4221531
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow-up of patients with congenital ocular toxoplasmosis.
    Peyron F; Wallon M; Bernardoux C
    N Engl J Med; 1996 Apr; 334(15):993-4. PubMed ID: 8596614
    [No Abstract]   [Full Text] [Related]  

  • 37. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.
    Delair E; Monnet D; Grabar S; Dupouy-Camet J; Yera H; Brézin AP
    Am J Ophthalmol; 2008 Dec; 146(6):851-5. PubMed ID: 18723143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Congenital ocular toxoplasmosis--ocular manifestations and prognosis after early diagnosis of infection].
    Garweg JG; Kodjikian L; Peyron F; Binquet C; Fleury J; Grange JD; Quantin C; Wallon M
    Klin Monbl Augenheilkd; 2005 Sep; 222(9):721-7. PubMed ID: 16175482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
    Sedan J
    Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
    [No Abstract]   [Full Text] [Related]  

  • 40. Clindamycin in the treatment of toxoplasmosis in AIDS.
    Iannucci AA; Hart LL
    Ann Pharmacother; 1992 May; 26(5):645-7. PubMed ID: 1591424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.